Published in Lancet on June 28, 1997
GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study | NCT00869674
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol (2007) 2.60
Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg (2000) 2.27
The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging (2013) 2.25
Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol (2010) 2.14
Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med (2005) 2.12
Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg (1999) 1.77
Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg (1999) 1.67
Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg (1999) 1.63
Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg (1999) 1.60
Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg (2001) 1.53
Label-free Detection of Lymph Node Metastases with US-guided Functional Photoacoustic Imaging. Radiology (2015) 1.48
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg (2005) 1.47
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg (2005) 1.45
Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol (2011) 1.41
Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg (2001) 1.39
Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg (2001) 1.38
Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging (2007) 1.30
Evaluation of breast lymphatic pathways with indocyanine green fluorescence imaging in patients with breast cancer. World J Surg (2008) 1.26
Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer (2005) 1.20
Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ (2001) 1.19
Three-dimensional optical imaging of microvascular networks within intact lymph node in vivo. J Biomed Opt (2010) 1.18
Axillary lymph node echo-guided fine-needle aspiration cytology enables breast cancer patients to avoid a sentinel lymph node biopsy. Preliminary experience and a review of the literature. Surg Today (2007) 1.18
Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol (1999) 1.18
Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg (2005) 1.17
Three-dimensional high-resolution imaging of gold nanorods uptake in sentinel lymph nodes. Nano Lett (2011) 1.17
Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol (2001) 1.16
Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg (2006) 1.15
Credentialing for breast lymphatic mapping: how many cases are enough? Ann Surg (1999) 1.14
Parametric imaging of the local attenuation coefficient in human axillary lymph nodes assessed using optical coherence tomography. Biomed Opt Express (2012) 1.12
Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg (1999) 1.11
Axillary staging of breast cancer and the sentinel node. J Clin Pathol (2000) 1.08
Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg (2001) 1.05
Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg (2003) 1.04
The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg (2012) 1.04
Secretory breast carcinoma with metastatic sentinel lymph node. World J Surg Oncol (2006) 1.02
The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian Sentinel Node Biopsy Study Group. Br J Cancer (2004) 1.01
A novel approach for sentinel lymph node identification using fluorescence imaging and image overlay navigation surgery in patients with breast cancer. World J Surg (2011) 1.01
Effectiveness of the treatment-phase of two-phase complex decongestive physiotherapy for the treatment of extremity lymphedema. Int J Clin Oncol (2007) 1.00
Implication of extracapsular invasion of sentinel lymph nodes in breast cancer: prediction of nonsentinel lymph node metastasis. World J Surg (2010) 0.98
High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study. Biomed Opt Express (2010) 0.98
Clinical aspects of sentinel node biopsy. Breast Cancer Res (2001) 0.97
Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg (2004) 0.96
Sentinel node biopsy in early vulvar cancer. Br J Cancer (2000) 0.96
Gray scale and power Doppler US in the preoperative evaluation of axillary metastases in breast cancer patients with no palpable lymph nodes. Eur Radiol (2005) 0.95
Complications of methylene blue dye in breast surgery: case reports and review of the literature. J Cancer (2010) 0.95
Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors. Cancer Res (2014) 0.94
NSABP breast cancer clinical trials: recent results and future directions. Clin Med Res (2003) 0.94
Primary tumour characteristics and axillary lymph node status in breast cancer. Br J Cancer (1999) 0.94
Protocol for ultrarapid immunostaining of frozen sections. J Clin Pathol (1999) 0.93
Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status. J Clin Pathol (2004) 0.93
Silica-coated gold nanoplates as stable photoacoustic contrast agents for sentinel lymph node imaging. Nanotechnology (2013) 0.92
Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol (2008) 0.92
Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br J Cancer (2003) 0.91
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat (2010) 0.91
Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis. PLoS One (2014) 0.90
Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus. Ann Surg (2006) 0.89
Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging (2003) 0.89
In vivo albumin labeling and lymphatic imaging. Proc Natl Acad Sci U S A (2014) 0.89
Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today (2008) 0.88
Sentinel node detection in pre-operative axillary staging. Eur J Nucl Med Mol Imaging (2004) 0.88
Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer. Br J Cancer (2012) 0.88
A novel finding of sentinel lymphatic channels in early stage breast cancer patients: which may influence detection rate and false-negative rate of sentinel lymph node biopsy. PLoS One (2012) 0.87
Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence. Eur J Nucl Med Mol Imaging (2007) 0.87
Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer. PLoS One (2015) 0.86
Video-assisted breast surgery can sample the second and third sentinel nodes to omit axillary node dissection for sentinel-node-positive patients. Surg Endosc (2009) 0.86
Fallacies of preoperative lymphoscintigraphy in detecting sentinel node in breast cancer. World J Surg Oncol (2005) 0.86
Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1. Br J Cancer (2002) 0.86
Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer. Eur J Nucl Med Mol Imaging (2005) 0.86
Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res (2001) 0.86
Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer. Breast Cancer Res (2007) 0.85
Molecular lymphatic mapping of the sentinel lymph node. Am J Pathol (2002) 0.84
Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate. Eur J Nucl Med Mol Imaging (2005) 0.84
Choices in surgery for older women with breast cancer. Breast Care (Basel) (2012) 0.84
Down-regulation of beta(1C) integrin in breast carcinomas correlates with high proliferative fraction, high histological grade, and larger size. Am J Pathol (2000) 0.84
Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg (2004) 0.84
Intraoperative identification of suspicious palpable lymph nodes as an integral part of sentinel node biopsy in patients with breast cancer. Surg Today (2008) 0.84
Lymphatic imaging: focus on imaging probes. Theranostics (2015) 0.83
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 0.83
Label-free optical imaging of lymphatic vessels within tissue beds in vivo. IEEE J Sel Top Quantum Electron (2015) 0.83
Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients. Eur J Nucl Med Mol Imaging (2004) 0.82
Real-time ultrasound elastography in 180 axillary lymph nodes: elasticity distribution in healthy lymph nodes and prediction of breast cancer metastases. BMC Med Imaging (2012) 0.82
Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node. Proc (Bayl Univ Med Cent) (2003) 0.81
Contrast enhanced ultrasound of sentinel lymph nodes. J Ultrason (2013) 0.81
Video-assisted breast surgery and sentinel lymph node biopsy guided by three-dimensional computed tomographic lymphography. Surg Endosc (2007) 0.80
Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance. Am J Clin Oncol (2013) 0.80
The reliability of sampling three to six nodes for staging breast cancer. J Clin Pathol (1999) 0.80
99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer. Surg Today (2006) 0.80
Clinical significance of skip metastasis in patients with gastric cancer. Gastric Cancer (2007) 0.80
Mapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injection. Onco Targets Ther (2014) 0.80
Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification. PLoS One (2012) 0.79
Evaluation of sentinel lymph node metastasis alone guided by three-dimensional computed tomographic lymphography in video-assisted breast surgery. Surg Endosc (2008) 0.79
Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients. Surg Today (2011) 0.79
Is intraoperative imprint cytology evaluation still feasible for the evaluation of sentinel lymph nodes for lobular carcinoma of the breast? Ann Surg Oncol (2011) 0.79
Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine. J Cancer Res Clin Oncol (2007) 0.79
Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg (2005) 0.79
Surgical sentinel lymph node biopsy in early breast cancer. Could it be avoided by performing a preoperative staging procedure? A pilot study. Med Sci Monit (2012) 0.78
A new model for predicting non-sentinel lymph node status in Chinese sentinel lymph node positive breast cancer patients. PLoS One (2014) 0.78
Optimization of sentinel lymph node biopsy in breast cancer using an operative gamma camera. World J Surg Oncol (2007) 0.78
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med (1981) 7.53
Effect of menstrual phase on surgical treatment of breast cancer. Lancet (1994) 5.66
Procollagen traverses the Golgi stack without leaving the lumen of cisternae: evidence for cisternal maturation. Cell (1998) 4.67
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer (1996) 4.46
ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat Cell Biol (1999) 4.38
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol (2002) 4.32
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst (1999) 4.04
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet (1998) 3.83
Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med (1993) 3.54
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer (1996) 3.07
Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer (1990) 3.01
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst (1999) 2.90
Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol (2001) 2.89
CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid. Nature (1999) 2.81
Correlative light-electron microscopy reveals the tubular-saccular ultrastructure of carriers operating between Golgi apparatus and plasma membrane. J Cell Biol (2000) 2.79
Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut (2009) 2.75
The specific-word frequency effect: implications for the representation of homophones in speech production. J Exp Psychol Learn Mem Cogn (2001) 2.74
The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study. Eur J Surg Oncol (2013) 2.69
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res (1996) 2.57
Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst (1995) 2.52
Phospholipase A2 and phospholipase C are activated by distinct GTP-binding proteins in response to alpha 1-adrenergic stimulation in FRTL5 thyroid cells. Proc Natl Acad Sci U S A (1986) 2.45
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol (2004) 2.31
Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer (1995) 2.30
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat (2001) 2.26
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst (1990) 2.25
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer (2001) 2.16
Patterns of integrin common chain beta 1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and size. J Pathol (1993) 2.12
Tamoxifen for breast cancer among hysterectomised women. Lancet (2002) 2.11
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer. Ann Oncol (2006) 2.10
A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer (2001) 2.09
The FtsJ/RrmJ heat shock protein of Escherichia coli is a 23 S ribosomal RNA methyltransferase. J Biol Chem (2000) 2.07
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol (1986) 2.05
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol (2010) 2.02
Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer (1990) 2.01
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
Will the sentinel lymph node (SLN) stand a second time--SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure. Ann Oncol (2001) 1.94
Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol (2011) 1.84
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol (2005) 1.72
Effect of closing dead space on seroma formation after mastectomy--a prospective randomized clinical trial. Eur J Surg Oncol (1993) 1.69
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol (2012) 1.69
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache (1993) 1.69
Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst (1981) 1.68
Outcome of special types of luminal breast cancer. Ann Oncol (2011) 1.67
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
The GM130 and GRASP65 Golgi proteins cycle through and define a subdomain of the intermediate compartment. Nat Cell Biol (2001) 1.63
A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line. Proc Natl Acad Sci U S A (1986) 1.62
An autoregulatory feedback loop directs the localized expression of the Drosophila CPEB protein Orb in the developing oocyte. Development (2001) 1.62
Central small size breast cancer: how to overcome the problem of nipple and areola involvement. Eur J Cancer (1993) 1.61
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol (2005) 1.60
A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol (1988) 1.58
Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med (2001) 1.57
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer (2003) 1.55
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol (2007) 1.54
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med (1998) 1.53
Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol (1998) 1.53
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women. J Clin Oncol (1999) 1.53
Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol (1996) 1.52
The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer (1994) 1.51
Should liver metastases of breast cancer be biopsied to improve treatment choice? Ann Oncol (2011) 1.50
Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50
Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer (1999) 1.48